Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

REPROS THERAPEUTICS INC. (RPRX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-17Jun-30-17Mar-31-17Dec-31-16Sep-30-16Jun-30-16Mar-31-16Dec-31-15
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Revenues and other income          
Interest income  0.00.00.00.00.10.00.00.0
Change in fair value of warrant liability  0.50.2      
    Total revenues and other income  0.30.00.00.00.10.00.00.0
            Total revenues and other income growth  548.0%-26.8%40.7%336.4%900.0%583.3%285.7%37.5%
Expenses          
Research and development  6.89.011.112.815.017.420.624.1
General and administrative  7.17.27.34.64.64.75.05.1
    Total expenses  14.016.318.417.319.622.025.529.2
    Net loss  -13.7-16.3-18.3-17.3-19.6-22.0-25.5-29.2
   
Basic and diluted loss per share  ($0.49)($0.62)($0.72)($0.70)($0.81)($0.91)($1.05)($1.20)
   
Shares used in loss per share calculation:          
Basic  92.379.275.1 73.173.072.9 
   
Diluted  23,072.713,679.312,659.56,098.16,098.06,098.024.324.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy